Thermo Fisher Scientific (TMO) Stock Forecast & Price Target

$580.63 -13.12 (-2.21%)

Closing price 02/4/2025 03:59 PM Eastern

Extended Trading

$579.40 -1.24 (-0.21%)

As of 04:04 AM Eastern

Thermo Fisher Scientific - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 22 Analyst Ratings

Sell
0

Hold
4

Buy
18

Based on 22 Wall Street analysts who have issued ratings for Thermo Fisher Scientific in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 22 analysts, 4 have given a hold rating, and 18 have given a buy rating for TMO.

Consensus Price Target

$658.00
13.32% Upside

According to the 22 analysts' twelve-month price targets for Thermo Fisher Scientific, the average price target is $658.00. The highest price target for TMO is $718.00, while the lowest price target for TMO is $610.00. The average price target represents a forecasted upside of 13.32% from the current price of $580.63.

Get the Latest News and Ratings for TMO and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Thermo Fisher Scientific and its competitors.

TMO Analyst Ratings Over Time

Type	Current Forecast 2/6/24 to 2/5/25	1 Month Ago 1/7/24 to 1/6/25	3 Months Ago 11/8/23 to 11/7/24	1 Year Ago 2/6/23 to 2/6/24
Strong Buy	0 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	18 Buy rating(s)	16 Buy rating(s)	17 Buy rating(s)	11 Buy rating(s)
Hold	4 Hold rating(s)	5 Hold rating(s)	4 Hold rating(s)	4 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$658.00	$650.05	$649.33	$596.00
Forecasted Upside	13.32% Upside	21.17% Upside	16.81% Upside	6.35% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

TMO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

TMO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Thermo Fisher Scientific Stock vs. The Competition

Type	Thermo Fisher Scientific	Medical Companies	S&P 500
Consensus Rating Score	2.82	2.82	2.53
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	13.32% Upside	15,482.40% Upside	13.01% Upside
News Sentiment Rating	Positive News See Recent TMO News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
2/3/2025	Scotiabank 5 of 5 stars	S. Nam Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Sector Perform ➝ Sector Perform	$605.00 ➝ $650.00	+9.44%
2/3/2025	Raymond James 4 of 5 stars	Andrew Cooper Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$650.00 ➝ $667.00	+11.46%
1/31/2025	Citigroup 3 of 5 stars	Patrick Donnelly Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$600.00 ➝ $650.00	+8.67%
1/31/2025	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Leonard Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$700.00 ➝ $715.00	+19.20%
1/31/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Couillard Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$660.00 ➝ $680.00	+12.98%
1/31/2025	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tejas Savant Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$647.00 ➝ $678.00	+12.52%
1/10/2025	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Burstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Market Perform ➝ Outperform	$630.00	+15.60%
12/13/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$675.00 ➝ $660.00	+26.05%
10/24/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$767.00 ➝ $718.00	+27.51%
10/24/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$680.00 ➝ $665.00	+17.72%
Get the Latest News and Ratings for TMO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Thermo Fisher Scientific and its competitors with MarketBeat's FREE daily newsletter.
10/24/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$630.00 ➝ $620.00	+9.38%
10/24/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$632.00 ➝ $622.00	+7.89%
10/23/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Equal Weight ➝ Equal Weight	$620.00 ➝ $610.00	+6.63%
10/22/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$656.00 ➝ $686.00	+16.92%
10/22/2024	Bernstein Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Perform ➝ Market Perform	$565.00 ➝ $625.00	+6.30%
10/14/2024	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Clark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$680.00	+13.74%
10/1/2024	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Johnson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$680.00	+9.93%
9/20/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$650.00 ➝ $670.00	+9.13%
6/3/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Hold ➝ Buy	$600.00 ➝ $650.00	+14.44%
4/30/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$660.00 ➝ $670.00	+17.13%
4/25/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$600.00 ➝ $610.00	+6.54%
4/10/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$550.00 ➝ $640.00	+10.94%
12/13/2023	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$575.00	+15.58%
10/26/2023	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Overweight ➝ Sector Weight
7/13/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Outperform	$620.00	+17.89%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 04:42 AM ET.

Should I Buy Thermo Fisher Scientific Stock? TMO Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, January 29, 2025. Please send any questions or comments about these Thermo Fisher Scientific pros and cons to contact@marketbeat.com.

Thermo Fisher Scientific
Bull Case

Here are some ways that investors could benefit from investing in Thermo Fisher Scientific Inc.:

The current stock price is $584.38, which is near its 12-month high of $627.88, indicating strong market performance and potential for growth.
Thermo Fisher Scientific Inc. has a consensus rating of "Moderate Buy" from analysts, suggesting positive sentiment and confidence in the company's future performance.
The company recently announced a $4.00 billion stock repurchase plan, which typically signals that management believes the stock is undervalued and can enhance shareholder value.
With a low dividend payout ratio of 9.78%, the company has significant room to increase dividends in the future, providing potential for income growth for investors.
Thermo Fisher Scientific Inc. operates in the life sciences sector, which is expected to grow due to increasing demand for healthcare solutions, positioning the company well for future expansion.

Thermo Fisher Scientific
Bear Case

Investors should be bearish about investing in Thermo Fisher Scientific Inc. for these reasons:

The stock has experienced insider selling, with the CEO selling 10,000 shares recently, which may raise concerns about the company's future prospects from a leadership perspective.
Despite a strong market capitalization of $223.52 billion, the company has a relatively high P/E ratio of 36.64, which could indicate that the stock is overvalued compared to its earnings.
The company has a beta of 0.76, suggesting lower volatility compared to the market, which may not appeal to investors seeking high-risk, high-reward opportunities.
Recent trading volumes have fluctuated, with a notable increase to 2,769,489 shares, which could indicate uncertainty among investors regarding the stock's direction.
Analysts have varying price targets, with some estimates as high as $686.00, indicating a lack of consensus on the stock's future performance, which may create uncertainty for potential investors.

TMO Forecast - Frequently Asked Questions

: According to the research reports of 22 Wall Street equities research analysts, the average twelve-month stock price forecast for Thermo Fisher Scientific is $658.00, with a high forecast of $718.00 and a low forecast of $610.00.
: 22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Thermo Fisher Scientific in the last year. There are currently 4 hold ratings and 18 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" TMO shares.
: According to analysts, Thermo Fisher Scientific's stock has a predicted upside of 13.32% based on their 12-month stock forecasts.
: Over the previous 90 days, Thermo Fisher Scientific's stock had 1 upgrade by analysts.
: Thermo Fisher Scientific has been rated by research analysts at Bank of America, Citigroup, Morgan Stanley, Raymond James, Sanford C. Bernstein, Scotiabank, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Thermo Fisher Scientific more than other "medical" companies. The consensus rating score for Thermo Fisher Scientific is 2.82 while the average consensus rating score for "medical" companies is 2.82. Learn more on how TMO compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

This page (NYSE:TMO) was last updated on 2/5/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thermo Fisher Scientific (TMO) Stock Forecast & Price Target